ADC Therapeutics (ADCT) Assets Growth (1y) (2020 - 2026)
ADC Therapeutics (ADCT) Assets Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - |
| 10 | ADC Therapeutics | 181.89 Mn | -49.12 Mn | 17.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.96% |
| Dec 31, 2025 | 0.36% |
| Sep 30, 2025 | -16.99% |
| Jun 30, 2025 | -13.51% |
| Mar 31, 2025 | -11.50% |
| Dec 31, 2024 | -9.25% |
| Sep 30, 2024 | -25.23% |
| Jun 30, 2024 | -26.71% |
| Mar 31, 2024 | -34.15% |
| Dec 31, 2023 | -27.72% |
| Sep 30, 2023 | -12.20% |
| Jun 30, 2023 | -2.53% |
| Mar 31, 2023 | -19.63% |
| Dec 31, 2022 | -20.57% |
| Sep 30, 2022 | -16.65% |
| Jun 30, 2022 | 12.08% |
| Mar 31, 2022 | 26.03% |
| Dec 31, 2021 | 20.30% |
| Dec 31, 2020 | 273.10% |